Autolus files for proposed US IPO

The UK gene therapy company Autolus Ltd has filed papers with the US Securities and Exchange Commission for a proposed initial public offering of its shares on Nasdaq. The offering will take the form of American Depositary Shares each representing one ordinary share in the company.

Full text available to subscribers only. Click here for information on subscribing to MedNous.


United Kingdom